Skip to main content
HighlightsHighlights Archive

Media Monitoring: 13th – 20th August

By August 19, 2022No Comments

New blood test can predict death or disability in patients within 24 hours of head injury

  • A simple blood test using a sample taken within 24 hours of a severe brain injury can ascertain the likelihood that a patient will survive or not, a new study has discovered
  • Researchers discovered that there was a correlation between levels of GFAP and UCH-L1 in a person’s blood and the severity of injury
  • By allowing doctors to understand the likely prognosis faster, life-saving treatments can be employed in necessary cases


Genetic mapping of tumours reveals how cancers grow

  • Researchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation
  • This has been made possible using a new technique called spatial transcriptomics, which allows scientists to see what genetic changes take place without breaking up the tissue they’re looking at
  • In a new study published in Nature, the researchers used spatial transcriptomics to create a cross-sectional map of a whole prostate, including areas of healthy and cancerous cells. By grouping cells according to similar genetic identity, they were surprised to see areas of supposedly healthy tissue that already had many of the genetic characteristics of cancer


Next steps in increasing capacity and operational resilience in urgent and emergency care ahead of winter – NHS England

  • Prepare for variants of COVID-19 and respiratory challenges, including an integrated COVID-19 and flu vaccination programme
  • Reduce hospital occupancy, through increasing capacity by the equivalent of at least 7,000 general and acute beds, through a mix of new physical beds, virtual wards, and improvements elsewhere in the pathway
  • Provide better support for people at home, including the scaling up of virtual wards and additional support for High Intensity Users with complex needs


Breast Cancer Now Tissue Bank celebrates 10 years of ground-breaking global research

  • Scientists at the UK’s largest breast cancer tissue bank are celebrating the remarkable advances it has enabled in breast cancer research during its first decade
  • The Breast Cancer Now Tissue Bank opened in 2012 to give researchers access to high-quality breast tissue, breast cells and blood samples from breast cancer patients. By doing so, the Breast Cancer Now Tissue Bank has accelerated progress towards faster diagnosis and better treatments


Dame Deborah’s campaign leads to record bowel cancer checks

  • Between May and July 2022, referrals for suspected lower gastro-intestinal cancers were at a record high, with over 170,500 people referred for bowel cancer checks during this period
  • Astonishingly, compared to the same period last year, these statistics have increased by over 30,000 and almost 80,000 higher than two years ago
  • This record-breaking campaign will benefit the aims of the NHS Long Term Plan, which has pledged that three-quarters of cancers will be diagnosed at stages one or two by 2028


Cancer biomarkers could be detected by smart contact lenses

  • The Terasaki Institute for Biomedical Innovation (TIBI) has developed a contact lens that can capture and detect exosomes, nanometre-sized vesicles found in bodily secretions, such as tears, which could be used as a cancer biomarker
  • Current ways of isolating exosomes are labour-intensive and take significant time to complete, usually around 10 hours
  • The scientists used a method that chemically modifies the microchamber surfaces to activate them for antibody binding. This is an alternative to current practices, in which it is essential to use metallic or nanocarbon materials in expensive clean-room settings


NHS expands lifesaving home testing kits for bowel cancer

  • Home-testing kits that can help detect early-stage bowel cancer will be rolled out to 58-year-olds in England for the first time, as part of a major expansion of the lifesaving screening programme
  • People aged 58 years will be automatically sent a Faecal Immunochemical Test (FIT) once eligible, which can detect early signs of bowel cancer by precisely recording the presence of any blood in just a tiny sample of poo
  • Around 830,000 additional people aged 58 years in England will now be eligible for the screening test, with London, which has the lowest uptake in the country, being one of the first places to roll out to this age group


Assessing men’s genetic risk of prostate cancer may lead to earlier diagnosis

  • New research has shown that assessing a man’s genetic risk of prostate cancer can improve referrals for those who require them and avoid invasive biopsies in low-risk patients
  • This could lead to much earlier diagnosis in men, significantly improving survival rates and optimising clinicians’ time
  • Prostate cancer is currently the second leading cause of death in UK men, while an estimated 14% of prostate cancer deaths could be avoided with early diagnosis


Natalie Creaney